Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Easom currently holds 198,000 shares of AN2 Therapeutics, Inc. (ANTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Easom has been a net seller of ANTX stock. They have purchased $53.8K and sold $1.6M worth of shares.
Eric Easom's most recent insider trade was on Mar 15, 2024, when they sold 198,000 shares at $0.00 per share.
Eric Easom serves as Executive at AN2 Therapeutics, Inc. (ANTX). They have executed 28 insider transactions totaling $1.6M over their tenure at the company.
Eric Easom holds the position of Executive at AN2 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Eric Easom has shown a selling trading pattern, with $53.8K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Easom was on Oct 21, 2022, when they sold $189.0K worth of ANTX shares. This transaction involved 11,601 shares at $16.29 per share.
Eric Easom currently owns 198,000 shares of AN2 Therapeutics, Inc. (ANTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Easom's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Easom has 28 Form 4 filings on record as an insider at AN2 Therapeutics, Inc..
Set alerts for Eric Easom and 40,000+ other insiders.